𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Germline variation in TP53 regulatory network genes associates with breast cancer survival and treatment outcome

✍ Scribed by Gallardo, M.; Post, S.M.


Book ID
123257094
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
61 KB
Volume
24
Category
Article
ISSN
1043-321X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Genetic polymorphisms in cell cycle regu
✍ Xuemei Zhang; Xiaoping Miao; Yongli Guo; Wen Tan; Yifeng Zhou; Tong Sun; Yonggan πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 226 KB

The tumor suppressor TP53 pathway plays a crucial role in preventing carcinogenesis through its ability to impose cell cycle arrest and apoptosis following DNA damage and oncogene activation. MDM2 is a key negative regulator of the TP53 pathway and is overexpressed in many cancers as oncoprotein. We

Detection of p53 gene mutation by rapid
✍ Richie Soong; Barry J. Iacopetta; Jennet M. Harvey; Gregory F. Sterrett; Hugh J. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 73 KB πŸ‘ 2 views

We examined the association between mutation of the p53 gene and survival in a large cohort of breast cancer patients. Using a rapid, non-isotopic single-strand conformation polymorphism (SSCP) method we screened for mutations in exons 4-10 of the p53 gene in 375 primary breast cancers from patients